Phosphaturic Mesenchymal Tumors: Rethinking the Clinical Diagnosis and Surgical Treatment

被引:5
|
作者
Liu, Yupeng [1 ,2 ]
He, Hongbo [1 ,2 ]
Zhang, Can [1 ,2 ]
Zeng, Hao [1 ]
Tong, Xiaopeng [1 ]
Liu, Qing [1 ,2 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Orthopaed, 87th Xiangya Rd, Changsha 410008, Peoples R China
[2] Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha 410008, Peoples R China
基金
中国博士后科学基金;
关键词
phosphaturic mesenchymal tumors; tumor-induced osteomalacia; hypophosphataemia; FGF-23; Tc99m-octreotide PET; CT; OSTEOMALACIA;
D O I
10.3390/jcm12010252
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The diagnosis of phosphaturic mesenchymal tumors (PMT) is easily delayed clinically, and their surgical treatment is unstandardized. This study aimed to evaluate our experience in the diagnosis and treatment of PMT and provide a research basis for the accurate and standardized treatment of PMT. Materials and Methods: Twelve patients diagnosed with PMT in our department and who underwent surgical treatment were included in this study. Preoperative demographic and clinical information were recorded. CT, MRI, and technetium-99m (Tc99m)-octreotide PET/CT imaging techniques were used to evaluate the general conditions and lesion boundaries of the tumors. Surgical treatment was performed using radical resection and microwave ablation-assisted extended curettage according to the lesion location and size. Patients were strictly followed up with and evaluated for oncological prognosis, radiological results, bone healing, serum ion levels, limb function, and pain level; the occurrence of complications was also recorded. Results: Three patients underwent radical resection, and nine underwent microwave ablation-assisted extended curettage. The average duration of symptoms in this group was 1.5 years (9-35 months) before diagnosis. Serum phosphate and AKP levels returned to normal one and two weeks postoperatively, respectively. There was no apparent specificity in the pathological findings; however, the immunohistochemistry of FGF-23 was positive, and the original fracture sites were effectively healed during the follow-up. The limb function and pain scores were significantly improved. The MSTS score increased from 15.3 to 29.0, and the VAS score decreased from 5.3 to 0.4. All patients recovered, and 90% resumed their original jobs. Conclusions: Accurate diagnosis and standardized surgical treatment are crucial to achieving a clinical cure for PMT. Combining clinical manifestations, biochemical examinations, imaging characteristics, and pathological findings is an effective way to diagnose PMT accurately. Radical resection and microwave ablation-assisted extended curettage are reliable surgical treatment methods for PMT.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Intracranial phosphaturic mesenchymal tumors Report of 2 cases
    Mathis, Derek A.
    Stehel, Edward J., Jr.
    Beshay, Joseph E.
    Mickey, Bruce E.
    Folpe, Andrew L.
    Raisanen, Jack
    JOURNAL OF NEUROSURGERY, 2013, 118 (04) : 903 - 907
  • [22] Genetics for the diagnosis and treatment of mesenchymal tumors
    Lasota, Jerzy
    Fanburg-Smith, Julie C.
    SEMINARS IN MUSCULOSKELETAL RADIOLOGY, 2007, 11 (03) : 215 - 230
  • [23] Selective Venous Catheterization for the Localization of Phosphaturic Mesenchymal Tumors
    Andreopoulou, Panagiota
    Dumitrescu, Claudia E.
    Kelly, Marilyn H.
    Brillante, Beth A.
    Peck, Carolee M. Cutler
    Wodajo, Felasfa M.
    Chang, Richard
    Collins, Michael T.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (06) : 1295 - 1302
  • [24] Thoracic phosphaturic mesenchymal tumors causing oncogenic osteomalacia
    Puthenveetil, Peter J.
    Hattab, Eyas M.
    Peacock, Munro
    Horn, Eric M.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2013, 20 (08) : 1057 - 1061
  • [25] Phosphaturic Mesenchymal Tumor Masquerading as Mesenchymal Tumors with Diverse Differential Diagnosis: Series of 4 Cases with Emphasis on Histomorphological Spectrum
    R. T. Rajeswarie
    Akhila Lakshmikantha
    S. Kannan
    V. Pillai
    K. Prasad
    Indian Journal of Surgical Oncology, 2021, 12 : 338 - 342
  • [26] Phosphaturic Mesenchymal Tumors with or without Phosphate Metabolism Derangements
    Montanari, Andrea
    Pirini, Maria Giulia
    Lotrecchiano, Ludovica
    Di Prinzio, Lorenzo
    Zavatta, Guido
    CURRENT ONCOLOGY, 2023, 30 (08) : 7478 - 7488
  • [27] Phosphaturic Mesenchymal Tumor Masquerading as Mesenchymal Tumors with Diverse Differential Diagnosis: Series of 4 Cases with Emphasis on Histomorphological Spectrum
    Rajeswarie, R. T.
    Lakshmikantha, Akhila
    Kannan, S.
    Pillai, V.
    Prasad, K.
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2021, 12 (SUPPL 2) : 338 - 342
  • [28] Phosphaturic mesenchymal tumors: radiological aspects and suggested imaging pathway
    Mohsin A. M. Hussein
    Francesco Pio Cafarelli
    Maria Teresa Paparella
    Winston J. Rennie
    Giuseppe Guglielmi
    La radiologia medica, 2021, 126 : 1609 - 1618
  • [29] Spinal phosphaturic mesenchymal tumors: Case report and literature review
    Wang, Xin
    Gao, Jun
    Han, Shiyuan
    Li, Yongning
    JOURNAL OF CLINICAL NEUROSCIENCE, 2019, 63 : 234 - 239
  • [30] PHOSPHATURIC MESENCHYMAL TUMORS - A POLYMORPHOUS GROUP CAUSING OSTEOMALACIA OR RICKETS
    WEIDNER, N
    CRUZ, DS
    CANCER, 1987, 59 (08) : 1442 - 1454